Circulating ESR1 mutations at the end of aromatase inhibitor adjuvant treatment and after relapse in breast cancer patients - Archive ouverte HAL Access content directly
Journal Articles Breast Cancer Research Year : 2018

Circulating ESR1 mutations at the end of aromatase inhibitor adjuvant treatment and after relapse in breast cancer patients

(1) , (2) , (2, 1) , (2) , (1) , (3, 1) , (2) , (4, 1, 2) , (2, 1)
1
2
3
4

Dates and versions

hal-02352867 , version 1 (07-11-2019)

Identifiers

Cite

Violette Allouchery, Ludivine Beaussire, Anne Perdrix, David Sefrioui, Laetitia Augusto, et al.. Circulating ESR1 mutations at the end of aromatase inhibitor adjuvant treatment and after relapse in breast cancer patients. Breast Cancer Research, 2018, 20 (1), ⟨10.1186/s13058-018-0968-0⟩. ⟨hal-02352867⟩
28 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More